cost-effectiveness of active screening for early identification of hiv in injection drug users

Background: acquired immunodeficiency syndrome is a behavioral disorder that can be detected via two methods, including active and passive screening. objectives: this study aimed to evaluate the cost-effectiveness of screening strategies of hiv/aids among injection drug users (idus) referring to the voluntary counseling and testing (vct) center and drop-in center (dic) of shiraz university of medical sciences. methods: this was a cross-sectional cost-effectiveness analysis to compare the cost-effectiveness of the two active and passive screening methods in 2015. the decision tree model, along with the treeage11 software, was used to analyze the data. results: the averages of cost and effectiveness were $989 and 987 subjects in the active screening method while they were $1,767 and 209 subjects in the passive screening method, respectively. the incremental cost-effectiveness ratio (icer) to early-diagnosed and averted cases was $855/39 for the active screening method and $1528/90 for the passive screening method. according to the findings of the study, the active screening method is more cost-effective than its passive counterpart. conclusions: according to the findings of the study, the active screening method is more cost-effective than its passive counterpart, and it is recommended to be used in these cases.